Feasibility study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced biliary tract cancer with carcinomatous ascites.
Phase of Trial: Phase II
Latest Information Update: 27 Mar 2012
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel; Paclitaxel
- Indications Biliary cancer
- Focus Therapeutic Use
- 27 Mar 2012 New trial record